Scarica l'app Stockscreener
42.08
1.30%
0.54
Dopo l'orario di chiusura:
42.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$41.54
Aprire:
$41.37
Volume 24 ore:
182.90K
Relative Volume:
0.42
Capitalizzazione di mercato:
$1.99B
Reddito:
$405.04M
Utile/perdita netta:
$-17.90M
Rapporto P/E:
-97.93
EPS:
-0.4297
Flusso di cassa netto:
$7.66M
1 W Prestazione:
+4.68%
1M Prestazione:
+5.33%
6M Prestazione:
+83.52%
1 anno Prestazione:
+57.43%
Intervallo 1D:
$41.22
$42.10
Intervallo di 1 settimana:
$39.98
$42.42
Portata 52W:
$21.97
$45.07
Artivion Inc Stock (AORT) Company Profile
Nome
Artivion Inc
Settore
Industria
Telefono
(770) 419-3355
Indirizzo
1655 ROBERTS BOULEVARD N W, KENNESAW
Confronta AORT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
42.08 | 1.96B | 405.04M | -17.90M | 7.66M | -0.4297 |
|
ABT
Abbott Laboratories
|
128.54 | 222.13B | 43.84B | 13.94B | 6.78B | 7.9979 |
|
BSX
Boston Scientific Corp
|
99.24 | 144.89B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
374.42 | 141.17B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.78 | 121.91B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
74.64 | 42.65B | 5.69B | 1.41B | 577.90M | 6.9828 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-13 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2025-06-17 | Iniziato | Canaccord Genuity | Buy |
| 2024-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-09-27 | Reiterato | Lake Street | Buy |
| 2022-08-08 | Iniziato | Lake Street | Buy |
| 2022-03-03 | Iniziato | Stifel | Buy |
Mostra tutto
Artivion Inc Borsa (AORT) Ultime notizie
Is Artivion Inc a good long term investmentMean Reversion Trades & Low Investment Wealth Tips - earlytimes.in
What insider trading reveals about Artivion Inc. stock2025 Stock Rankings & Free Verified High Yield Trade Plans - newser.com
How resilient is Artivion Inc. stock in market downturnsJuly 2025 Price Swings & Weekly High Return Stock Opportunities - Trung tâm Dự báo KTTV quốc gia
Applying big data sentiment scoring on Artivion Inc.Weekly Stock Recap & Consistent Growth Equity Picks - newser.com
Candlestick signals on Artivion Inc. stock todayPortfolio Performance Report & Weekly Breakout Stock Alerts - newser.com
How sustainable is Artivion Inc. stock dividend payoutMarket Risk Summary & Safe Capital Growth Trade Ideas - newser.com
How Artivion Inc. stock reacts to stronger dollar2025 Market Trends & Expert Curated Trade Ideas - newser.com
BlackRock reports 5,977,264 AORT shares, equal to 12.7% ownership - Stock Titan
Why Artivion Inc. stock remains stable2025 Earnings Impact & Advanced Swing Trade Entry Plans - Trung tâm Dự báo KTTV quốc gia
Will Artivion Inc. stock benefit from AI adoptionJuly 2025 Movers & Reliable Volume Spike Alerts - newser.com
Is it too late to sell Artivion Inc.Weekly Trade Summary & Low Drawdown Investment Strategies - newser.com
Treasury Yields: How Artivion Inc. stock performs in weak economyWeekly Risk Summary & Daily Technical Stock Forecast Reports - Trung tâm Dự báo KTTV quốc gia
Artivion, Inc. (AORT) Stock Forecasts - Yahoo Finance
Firing on All Cylinders: Artivion (NYSE:AORT) Q2 Earnings Lead the Way - Yahoo Finance
What analysts say about Klaviyo Inc stockResistance Breakout Alerts & Outstanding Growth Portfolio - earlytimes.in
Is Artivion Inc. (CYL) stock positioned for secular growthWeekly Trade Summary & Weekly High Return Forecasts - newser.com
How to use a screener to detect Artivion Inc. breakoutsEntry Point & High Accuracy Trade Signal Alerts - newser.com
Will Artivion Inc. stock keep raising dividends2025 Trade Ideas & Weekly Watchlist for Hot Stocks - newser.com
3 Reasons to Sell AORT and 1 Stock to Buy Instead - The Globe and Mail
What data driven models say about Artivion Inc.’s futureWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
Artivion, Inc. (AORT) stock price, news, quote and history - Yahoo
How Investors Are Reacting To Artivion (AORT) Clinical Trial Results for Hybrid Aortic Dissection Device - Yahoo Finance
Artivion reports positive data from AMDS trials for aortic disease By Investing.com - Investing.com Nigeria
Risk adjusted return profile for Artivion Inc. analyzed2025 Technical Patterns & Risk Managed Investment Signals - newser.com
What catalysts could drive Artivion Inc. stock higherM&A Rumor & High Accuracy Swing Trade Signals - newser.com
Is Artivion Inc. stock safe for conservative investors2025 Price Targets & AI Optimized Trading Strategy Guides - newser.com
Can Artivion Inc. hit a new high this monthOil Prices & AI Driven Price Forecasts - newser.com
Artivion (AORT) Shows Promising Results from Key Cardiovascular Trials - GuruFocus
Artivion reports positive data from AMDS trials for aortic disease - Investing.com India
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting - PR Newswire
Stocks with Diverging Prospects: Snowflake a Buy, Mercury & Artivion a SellNews and Statistics - IndexBox
Positive AMDS Clinical Results Might Change the Case for Investing in Artivion (AORT) - Sahm
Artivion Inc.’s volatility index tracking explainedJuly 2025 EndofMonth & Verified Technical Signals - newser.com
Artivion stock price target raised to $47 from $42 at Citizens - Investing.com Nigeria
Using data filters to optimize entry into Artivion Inc.Earnings Growth Summary & Community Verified Watchlist Alerts - newser.com
Trend analysis for Artivion Inc. this week2025 AllTime Highs & Consistent Return Investment Signals - newser.com
Custom watchlist performance reports with Artivion Inc.Weekly Stock Report & Technical Analysis for Trade Confirmation - newser.com
Artivion Inc Azioni (AORT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.73%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):